Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,517 | 60 | 97.0% |
| Food and Beverage | $353.13 | 19 | 1.8% |
| Consulting Fee | $250.00 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $19,833 | 65 | $0 (2024) |
| Merck Sharp & Dohme LLC | $141.81 | 7 | $0 (2024) |
| Ethicon Inc. | $47.39 | 2 | $0 (2024) |
| ITI, Inc. | $34.64 | 2 | $0 (2023) |
| Medtronic, Inc. | $34.60 | 2 | $0 (2024) |
| Becton, Dickinson and Company | $15.05 | 1 | $0 (2023) |
| Lundbeck LLC | $13.24 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,681 | 14 | ABBVIE INC. ($1,548) |
| 2023 | $3,098 | 13 | ABBVIE INC. ($3,019) |
| 2022 | $4,436 | 17 | ABBVIE INC. ($4,375) |
| 2021 | $10,905 | 36 | AbbVie Inc. ($10,892) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/30/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/20/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/13/2024 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Endo-Mechanical | ||||||
| 05/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/13/2024 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/15/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/30/2024 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | Medtronic, Inc. | BIS (Device) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Brain Monitoring | ||||||
| 12/21/2023 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/28/2023 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/14/2023 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/02/2023 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/24/2023 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/20/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA, RECARBRIO | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/04/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/18/2023 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/22/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/21/2023 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 13 | 13 | $7,056 | $1,092 |
| 2020 | 2 | 29 | 29 | $12,460 | $2,058 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 13 | 13 | $7,056 | $1,092 | 15.5% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 16 | 16 | $7,552 | $1,198 | 15.9% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 13 | 13 | $4,908 | $859.05 | 17.5% |
About Gregory Romano
Gregory Romano is a Nurse Anesthetist, Certified Registered healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2019. The National Provider Identifier (NPI) number assigned to this provider is 1538632773.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gregory Romano has received a total of $20,120 in payments from pharmaceutical and medical device companies, with $1,681 received in 2024. These payments were reported across 80 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,517).
As a Medicare-enrolled provider, Romano has provided services to 42 Medicare beneficiaries, totaling 42 services with total Medicare billing of $3,149. Data is available for 2 years (2020–2021), covering 3 distinct procedure/service records.
Practice Information
- Specialty Nurse Anesthetist, Certified Registered
- Other Specialties Certified Registered
- Location Pittsburgh, PA
- Active Since 01/10/2019
- Last Updated 01/10/2019
- Taxonomy Code 367500000X
- Entity Type Individual
- NPI Number 1538632773
Products in Payments
- DALVANCE (Drug) $19,536
- TEFLARO (Drug) $250.00
- DIFICID (Drug) $89.61
- BRIDION (Drug) $52.20
- VRAYLAR (Drug) $47.76
- Monarch Platform (Device) $47.39
- CAPLYTA (Drug) $34.64
- BIS (Device) $34.60
- AccuCath (Device) $15.05
- BRINTELLIX (Drug) $13.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Anesthetist, Certified Registered Doctors in Pittsburgh
Mr. Chad Braham, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $1,732
Richard Henker
Nurse Anesthetist, Certified Registered — Payments: $1,320
Matthew Cline, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $1,273
Colleen Costick, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $1,254
Karen Ferguson
Nurse Anesthetist, Certified Registered — Payments: $1,231
Lisa Jancel
Nurse Anesthetist, Certified Registered — Payments: $904.43